Vaccines against influenza A (H1N1) pandemic
- PMID: 20304259
- DOI: 10.1016/j.arcmed.2009.10.008
Vaccines against influenza A (H1N1) pandemic
Abstract
Background and aims: The World Health Organization (WHO) has reported, as of September 2009, that the influenza A (H1N1) influenza pandemic has originated >300,000 laboratory-confirmed cases and 3917 deaths in 191 countries. It is recognized that pandemic vaccines have their greatest impact as a preventive strategy when administered before or near the peak incidence of cases in an outbreak. Therefore, vaccination campaigns should be in place when influenza A (H1N1) 2009 vaccines are available. We undertook this study to provide updated information on clinical evaluation of influenza A (H1N1) vaccines and review recommendations for influenza A (H1N1) vaccination campaigns and public health policy.
Methods: The following methods were used: 1) review of registry at ClinicalTrials.gov. 2) search of PubMed Central (PMC) for influenza A (H1N1) vaccine. 3) review of recommendations of WHO, Mexican Health Secretariat (SSA) and Advisory Committee on Immunization Practices (ACIP) on influenza A (H1N1) vaccination campaigns.
Results: Until October 1, 2009 there were 11 available influenza A (H1N1) candidate strains provided by WHO Global Influenza Surveillance Network. ClinicalTrials.gov registers 45 phase I and II clinical trials evaluating immunogenicity and safety of influenza A (H1N1) vaccines. Preliminary results support administration of a single dose and use of adjuvants. Main recommendations of WHO, SSA and ACIP include epidemiologic considerations, objectives, definition of target groups and reinforcement of other mitigation measures.
Conclusions: The present pandemic of influenza A (H1N1) has shown mild to moderate severity. Vaccination strategies in Mexico will have the objective of decreasing severe outcomes, slowing transmission, protecting groups at increased risk of infection, complications, or death, and preventing overload of health services. Control of the pandemic should include reinforcement of other non-pharmacologic measures of mitigation and, importantly, an adequate strategy of social communication.
Similar articles
-
2009 pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009.MMWR Morb Mortal Wkly Rep. 2009 Aug 28;58(33):913-8. MMWR Morb Mortal Wkly Rep. 2009. PMID: 19713879
-
Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination.Vaccine. 2010 May 14;28(22):3758-66. doi: 10.1016/j.vaccine.2010.03.072. Epub 2010 Apr 7. Vaccine. 2010. PMID: 20380902
-
Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase.Vaccine. 2010 Aug 9;28(35):5703-10. doi: 10.1016/j.vaccine.2010.06.049. Epub 2010 Jun 30. Vaccine. 2010. PMID: 20600497
-
Influenza a (H1N1) outbreak and challenges for pharmacotherapy.Indian J Physiol Pharmacol. 2009 Apr-Jun;53(2):113-26. Indian J Physiol Pharmacol. 2009. PMID: 20112815 Review.
-
The 2009 A (H1N1) influenza virus pandemic: A review.Vaccine. 2010 Jul 12;28(31):4895-902. doi: 10.1016/j.vaccine.2010.05.031. Epub 2010 May 27. Vaccine. 2010. PMID: 20553769 Review.
Cited by
-
The first influenza pandemic of the new millennium.Influenza Other Respir Viruses. 2011 May;5(3):157-66. doi: 10.1111/j.1750-2659.2011.00231.x. Epub 2011 Feb 28. Influenza Other Respir Viruses. 2011. PMID: 21477134 Free PMC article. Review.
-
Healthcare workers and H1N1 vaccination: does having a chronic disease make a difference?Vaccine. 2012 Feb 1;30(6):1064-70. doi: 10.1016/j.vaccine.2011.12.037. Epub 2011 Dec 15. Vaccine. 2012. PMID: 22178521 Free PMC article.
-
Clinical data to be used as a foundation to combat Covid-19 vaccine hesitancy.J Interprof Educ Pract. 2022 Mar;26:100483. doi: 10.1016/j.xjep.2021.100483. Epub 2021 Dec 11. J Interprof Educ Pract. 2022. PMID: 34926837 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials